|
1
|
Crosbie EJ, Kitson SJ, McAlpine JN,
Mukhopadhyay A, Powell ME and Singh N: Endometrial cancer. Lancet.
399:1412–1428. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hafizz AMHA, Zin RRM, Aziz NHA, Kampan NC
and Shafiee MN: Beyond lipid-lowering: Role of statins in
endometrial cancer. Mol Biol Rep. 47:8199–8207. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, Huang C, Kavlashvili T, Fronk A,
Zhang Y, Wei Y, Dai D, Devor EJ, Meng X, Thiel KW, et al: Loss of
progesterone receptor through epigenetic regulation is associated
with poor prognosis in solid tumors. Am J Cancer Res. 10:1827–1843.
2020.PubMed/NCBI
|
|
4
|
Francis SR, Ager BJ, Do OA, Huang YJ,
Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD and Gaffney
DK: Recurrent early stage endometrial cancer: Patterns of
recurrence and results of salvage therapy. Gynecol Oncol.
154:38–44. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bregar AJ, Melamed A, Diver E, Clemmer JT,
Uppal S, Schorge JO, Rice LW, Del Carmen MG and Rauh-Hain JA:
Minimally invasive staging surgery in women with early-stage
endometrial cancer: Analysis of the national cancer data base. Ann
Surg Oncol. 24:1677–1687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Connor EV and Rose PG: Management
strategies for recurrent endometrial cancer. Expert Rev Anticancer
Ther. 18:873–885. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pölcher M, Rottmann M, Brugger S, Mahner
S, Dannecker C, Kiechle M, Brambs C, Grab D, Anthuber C, von Koch
F, et al: Lymph node dissection in endometrial cancer and clinical
outcome: A population-based study in 5546 patients. Gynecol Oncol.
154:65–71. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wessler S, Aberger F and Hartmann TN: The
sound of tumor cell-microenvironment communication-composed by the
cancer cluster salzburg research network. Cell Commun Signal.
15:202017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lauko A, Mu Z, Gutmann DH, Naik UP and
Lathia JD: Junctional adhesion molecules in cancer: A paradigm for
the diverse functions of cell-cell interactions in tumor
progression. Cancer Res. 80:4878–4885. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paskeh MDA, Entezari M, Mirzaei S,
Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M,
Hushmandi K, et al: Emerging role of exosomes in cancer progression
and tumor microenvironment remodeling. J Hematol Oncol. 15:832022.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei H, Chen Q, Lin L, Sha C, Li T, Liu Y,
Yin X, Xu Y, Chen L, Gao W, et al: Regulation of exosome production
and cargo sorting. Int J Biol Sci. 17:163–177. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cully M: Exosome-based candidates move
into the clinic. Nat Rev Drug Discov. 20:6–7. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Au Yeung CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baroni S, Romero-Cordoba S, Plantamura I,
Dugo M, D'Ippolito E, Cataldo A, Cosentino G, Angeloni V, Rossini
A, Daidone MG and Iorio MV: Exosome-mediated delivery of miR-9
induces cancer-associated fibroblast-like properties in human
breast fibroblasts. Cell Death Dis. 7:e23122016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Che X, Jian F, Chen C, Liu C, Liu G and
Feng W: PCOS serum-derived exosomal miR-27a-5p stimulates
endometrial cancer cells migration and invasion. J Mol Endocrinol.
64:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jing L, Hua X, Yuanna D, Rukun Z and
Junjun M: Exosomal miR-499a-5p inhibits endometrial cancer growth
and metastasis via targeting VAV3. Cancer Manag Res.
12:13541–13552. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao ZQ, Wang JF, Chen DH, Ma XS, Wu Y,
Tang Z and Dang XW: Long non-coding RNA GAS5 suppresses pancreatic
cancer metastasis through modulating miR-32-5p/PTEN axis. Cell
Biosci. 7:662017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang H, Tang Y, Zhang H and Zhang C:
MiR-32-5p regulates radiosensitization, migration and invasion of
colorectal cancer cells by targeting TOB1 gene. Onco Targets Ther.
12:9651–9661. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin Y and Wang H: Circ_0078607 inhibits
the progression of ovarian cancer via regulating the miR-32-5p/SIK1
network. J Ovarian Res. 15:32022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang P, Liang T, Chen Y, Wang X, Wu T,
Xie Z, Luo J, Yu Y and Yu H: Circulating exosomal miRNAs as Novel
biomarkers for stable coronary artery disease. Biomed Res Int.
2020:35939622020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou L, Wang W, Wang F, Yang S, Hu J, Lu
B, Pan Z, Ma Y, Zheng M, Zhou L, et al: Plasma-derived exosomal
miR-15a-5p as a promising diagnostic biomarker for early detection
of endometrial carcinoma. Mol Cancer. 20:572021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berek JS, Matias-Guiu X, Creutzberg C,
Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D and Concin
N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer
Committee, : FIGO staging of endometrial cancer: 2023. Int J
Gynaecol Obstet. 162:383–394. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan Y, Wang X, Li Y, Yan PY and Zhang H:
Human umbilical cord blood mesenchymal stem cells-derived exosomal
microRNA-503-3p inhibits progression of human endometrial cancer
cells through downregulating MEST. Cancer Gene Ther. 29:1130–1139.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu Z, Chen Z, Wang M, Zhang M, Chen Y,
Yang X, Zhou C, Liu Y, Hong L and Zhang L: Detection of plasma
exosomal miRNA-205 as a biomarker for early diagnosis and an
adjuvant indicator of ovarian cancer staging. J Ovarian Res.
15:272022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu W, Yang D, Chen L, Liu Q, Wang W, Yang
Z, Shang A, Quan W and Li D: Plasma exosomal miRNA-139-3p is a
novel biomarker of colorectal cancer. J Cancer. 11:4899–4906. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taghehchian N, Lotfi M, Zangouei AS,
Akhlaghipour I and Moghbeli M: MicroRNAs as the critical regulators
of Forkhead box protein family during gynecological and breast
tumor progression and metastasis. Eur J Med Res. 28:3302023.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie SM, Zhang Q and Jiang L: Current
knowledge on exosome biogenesis, cargo-sorting mechanism and
therapeutic implications. Membranes (Basel). 12:4982022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang N, Dai Q, Su X, Fu J, Feng X and
Peng J: Role of PI3K/AKT pathway in cancer: The framework of
malignant behavior. Mol Biol Rep. 47:4587–4629. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Y, Sun MM, Zhang GG, Yang J, Chen KS,
Xu WW and Li B: Targeting PI3K/Akt signal transduction for cancer
therapy. Signal Transduct Target Ther. 6:4252021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pavlidou A and Vlahos NF: Molecular
alterations of PI3K/Akt/mTOR pathway: A therapeutic target in
endometrial cancer. ScientificWorldJournal. 2014:7097362014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Buhtoiarova TN, Brenner CA and Singh M:
Endometrial carcinoma: Role of current and emerging biomarkers in
resolving persistent clinical dilemmas. Am J Clin Pathol. 145:8–21.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu ZY, Tang LD, Zhou Q, Xiao L and Cao Y:
Aberrant promoter hypermethylation of p16 gene in endometrial
carcinoma. Tumour Biol. 36:1487–1491. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Muinelo-Romay L, Casas-Arozamena C and
Abal M: Liquid biopsy in endometrial cancer: New opportunities for
personalized oncology. Int J Mol Sci. 19:23112018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Falcone G, Felsani A and D'Agnano I:
Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res.
34:322015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bjørnetrø T, Redalen KR, Meltzer S,
Thusyanthan NS, Samiappan R, Jegerschöld C, Handeland KR and Ree
AH: An experimental strategy unveiling exosomal microRNAs 486-5p,
181a-5p and 30d-5p from hypoxic tumour cells as circulating
indicators of high-risk rectal cancer. J Extracell Vesicles.
8:15672192019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng M, Hou L, Ma Y, Zhou L, Wang F,
Cheng B, Wang W, Lu B, Liu P, Lu W and Lu Y: Exosomal let-7d-3p and
miR-30d-5p as diagnostic biomarkers for non-invasive screening of
cervical cancer and its precursors. Mol Cancer. 18:762019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Panda AC: Circular RNAs Act as miRNA
sponges. Adv Exp Med Biol. 1087:67–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zeng ZL, Zhu Q, Zhao Z, Zu X and Liu J:
Magic and mystery of microRNA-32. J Cell Mol Med. 25:8588–8601.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu YJ, Zhou HG, Chen LH, Qu DC, Wang CJ,
Xia ZY and Zheng JH: MiR-32-5p regulates the proliferation and
metastasis of cervical cancer cells by targeting HOXB8. Eur Rev Med
Pharmacol Sci. 23:87–95. 2019.PubMed/NCBI
|
|
41
|
Wang R, Huang Z, Qian C, Wang M, Zheng Y,
Jiang R and Yu C: LncRNA WEE2-AS1 promotes proliferation and
inhibits apoptosis in triple negative breast cancer cells via
regulating miR-32-5p/TOB1 axis. Biochem Biophys Res Commun.
526:1005–1012. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lawrence MS, Stojanov P, Mermel CH,
Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander
ES and Getz G: Discovery and saturation analysis of cancer genes
across 21 tumour types. Nature. 505:495–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wei ST, Zhang J, Zhao R, Shi R, An L, Yu
Z, Zhang Q, Zhang J, Yao Y, Li H and Wang H: Histone lactylation
promotes malignant progression by facilitating USP39 expression to
target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma.
Cell Death Discov. 10:1212024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma LJ, Huang WN, Liang XL, Bai G, Wang X,
Jiang H, Xin Y, Hu L, Chen X and Liu C: Inhibition of squalene
epoxidase linking with PI3K/AKT signaling pathway suppresses
endometrial cancer. Cancer Sci. 114:3595–3607. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li C, Zhou T, Chen J, Li R, Chen H, Luo S,
Chen D, Cai C and Li W: The role of exosomal miRNAs in cancer. J
Transl Med. 20:62022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nail HM, Chiu CC, Leung CH, Ahmed MMM and
Wang HMD: Exosomal miRNA-mediated intercellular communications and
immunomodulatory effects in tumor microenvironments. J Biomed Sci.
30:692023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fasken MB, Morton DJ, Kuiper EG, Jones SK,
Leung SW and Corbett AH: The RNA exosome and human disease. Methods
Mol Biol. 2062:3–33. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yao Y, Shi L and Zhu X: Four
differentially expressed exosomal miRNAs as prognostic biomarkers
and therapy targets in endometrial cancer: Bioinformatic analysis.
Medicine (Baltimore). 102:e349982023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li BL, Lu W, Qu JJ, Ye L, Du GQ and Wan
XP: Loss of exosomal miR-148b from cancer-associated fibroblasts
promotes endometrial cancer cell invasion and cancer metastasis. J
Cell Physiol. 234:2943–2953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Y, Guo MM, Lin DM, Liang D, Zhao L,
Zhao R and Wang Y: Docetaxel-loaded exosomes for targeting
non-small cell lung cancer: preparation and evaluation in vitro and
in vivo. Drug Deliv. 28:1510–1523. 2021. View Article : Google Scholar : PubMed/NCBI
|
